M
Maxime Dougados
Researcher at University of Paris
Publications - 1144
Citations - 78022
Maxime Dougados is an academic researcher from University of Paris. The author has contributed to research in topics: Rheumatoid arthritis & Ankylosing spondylitis. The author has an hindex of 134, co-authored 1054 publications receiving 69979 citations. Previous affiliations of Maxime Dougados include French Institute of Health and Medical Research & Paris Descartes University.
Papers
More filters
Body weight, body composition and bone turnover changes in patients with spondyloarthropathy receiving anti-tumour necrosis factor therapy
TL;DR: Treatment with anti TNF in SpA is associated with an increase of BMD which results from a decrease of bone resorption, and increase in body weight and lean mass is observed in parallel with a increase in IGF1.
Journal Article
Can we combine patient's and doctor's perspective when assessing rheumatoid arthritis disease activity?
Journal ArticleDOI
Clinical characteristics of non-radiographic versus radiographic axial spondyloarthritis in Asia and non-radiographic axial spondyloarthritis in other regions: results of the cross-sectional ASAS-COMOSPA study.
Mitsumasa Kishimoto,Keisuke Ono,Sho Fukui,Satoshi Kawaai,Gautam A. Deshpande,Kazuki Yoshida,Naomi Ichikawa,Yuko Kaneko,Taku Kawasaki,Kazuo Matsui,Mitsuhro Morita,Kurisu Tada,Naoho Takizawa,Naoto Tamura,Atsuo Taniguchi,Yoshinori Taniguchi,Shigeyoshi Tsuji,Masato Okada,Shigeto Kobayashi,Yoshinori Komagata,Clementina López-Medina,Anna Molto,Désirée van der Heijde,Maxime Dougados,Tetsuya Tomita,Shinya Kaname +25 more
TL;DR: In this paper, the authors delineate characteristics of non-radiographic axial spondyloarthritis (nr-axSpA) in Asia versus non-Asian regions, and compare radiographic axSpA (r-axSca) with nr-sca within Asia.
Proceedings ArticleDOI
SAT0199 Switch from innovator etanercept to biosimilar etanercept in inflammatory rheumatic diseases: the experience of cochin university hospital paris-france.
TL;DR: The probability to switch from etanercept innovator to bETN was mainly related to physicians’ behavior and using an open design, the percentage of patients complaining of a lower efficiency and/or a worse safety profile of the biosimilar was high.
Journal ArticleDOI
Practice patterns in outpatient rheumatology: a pilot evaluation of medical file content.
Jacques Fechtenbaum,Henri Nataf,Christophe Hudry,Véroniqe Gaud Listrat,Christian Roux,Maxime Dougados +5 more
TL;DR: This pilot study establishes the feasibility of practice pattern evaluation by rheumatologists and concludes that follow-up investigations are needed to evaluate the impact of medical record evaluations on quality of care.